„Moderna” It aims to make a single ‘booster’ vaccine that will protect against both covid-19 and influenza within two years,” said its chief executive.
Stefan Bansel said the combined vaccine – which would protect against covid-19, influenza and RSV (common respiratory virus) – could be available before the winter infectious season of 2023. The Guardian.
“Our goal is to be able to have a booster vaccine so that we do not have compliance problems where people do not want to receive two to three doses,” he told a panel at the World Economic Forum in Davos. “The best-case scenario would be the fall of 2023.”
Bansel has previously said that people may need a fourth dose of the vaccine this fall as booster vaccine protection declines over the coming months.
He also said that the “Moderna” vaccine, which specifically targets the coronavirus variant omicron, has almost completed its development and will enter clinical development in the coming period. The US drug company expects to be able to share the data with regulators around March, he added.